Publications dans lesquelles il/elle collabore avec Constantino Fondevila Campo (19)

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

2021

  1. COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study

    Gut, Vol. 70, Núm. 10, pp. 1914-1924

  2. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155

  3. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

    Gastroenterology, Vol. 160, Núm. 4, pp. 1151-1163.e3

  4. Transcriptomic profiling of the liver sinusoidal endothelium during cirrhosis reveals stage-specific secretory signature

    Cancers, Vol. 13, Núm. 11

2020

  1. Donation after circulatory death liver transplantation: consensus statements from the Spanish Liver Transplantation Society

    Transplant International, Vol. 33, Núm. 8, pp. 902-916

  2. Resultados de una encuesta sobre el soporte nutricional perioperatorio en la cirugía pancreática y biliar en España

    Nutricion hospitalaria, Vol. 37, Núm. 2, pp. 238-242

2019

  1. A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain

    Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567

  2. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial

    Annals of Surgery, Vol. 270, Núm. 5, pp. 738-746

  3. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

    Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665

  4. Reply to: “Normothermic regional perfusion – What is the benefit?”

    Journal of Hepatology

  5. The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

    Journal of Hepatology

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  2. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

2015

  1. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience

    HPB, Vol. 17, Núm. 5, pp. 387-393

2014

  1. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: A case-control study

    Clinical Transplantation, Vol. 28, Núm. 7, pp. 821-828

  2. IV Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH) 2012. Trasplante hepático con injertos no convencionales: Bipartición hepática (split) y donante en asistolia

    Cirugia Espanola, Vol. 92, Núm. 3, pp. 157-167

  3. Response to circulatory death determination in uncontrolled organ donors: A panel viewpoint

    Annals of Emergency Medicine